McNeil Seeks Supreme Court Opinion On OTC Labeling Pre-emption
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare argues in a consumer injury lawsuit that the Supreme Court's 2009 decision in Wyeth v. Levine does not apply to nonprescription pharmaceuticals because OTC and Rx drugs are covered by different regulatory labeling schemes.
You may also be interested in...
Supreme Court Again Asked To Address Generic Firms' Liability For Inadequate Warning Labels
Actavis is making a second appeal to the Supreme Court to consider whether a generic manufacturer can be sued for failing to add safety information to its labeling that is not in the brand's label
High Court’s Wyeth v. Levine Ruling Returns Pre-Emption Status Quo
The Supreme Court's ruling in Wyeth v. Levine dashes pharmaceutical industry hopes for broad protection from state product liability lawsuits, but is not expected to trigger a sea-change in current industry operations
Tort Attorneys Concerned By State Claim Pre-emption Described In OTC Rule
An FDA proposed rule has a lawyer's group concerned the agency is moving toward a policy of pre-empting state tort law regarding liability claims linked to over-the-counter products